Glaucoma Risk In Children Hinges On Steroid Therapy

Glaucoma Risk In Children Hinges On Steroid Therapy Overview The use of glucocorticoids after pediatric cataract surgery is essential for preventing inflammation, but it poses risks such as secondary glaucoma and suppression of the hypothalamic-pituitary-adrenal axis. This study aimed to evaluate glaucoma outcomes in children receiving either high-dose or low-dose glucocorticoid therapy

Kawasaki disease: Meta Analysis Reveals A Capable Steroid Combination Therapy

Kawasaki disease: Meta Analysis Reveals A Capable Steroid Combination Therapy Overview Kawasaki disease (KD) poses significant challenges as an acute vasculitis primarily affecting the coronary arteries in children, potentially leading to fatal complications if left untreated. Corticosteroids, notably glucocorticoids, have emerged as crucial therapeutic agents in managing KD and associated cutaneous wounds.

Ocular Surgery In Infants And Post-Op Eye Drop Risks

Ocular Surgery In Infants And Post-Op Eye Drop Risks Overview This clinical observational cohort study delves into the prevalence and risk factors associated with hypothalamus-pituitary-adrenal (HPA) axis suppression in infants subjected to glucocorticoid (GC) eye drops subsequent to ocular surgery, focusing on cataract and glaucoma procedures. The research aims to discern the

Glaucoma Risk In Children Hinges On Steroid Therapy